Latest Breaking News On - தாக்கம் முதலீடு நிதி - Page 2 : comparemela.com
Northwestern Mutual Announces $100-Million Impact Investing Fund to Address Inequality and the Racial Wealth Gap
urbanmilwaukee.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urbanmilwaukee.com Daily Mail and Mail on Sunday newspapers.
Northwestern Mutual launches $100 million investment fund focused on Black and African American communities
biztimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztimes.com Daily Mail and Mail on Sunday newspapers.
Bright Power Raises $24 5M in Growth Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Social innovation is a path to lasting change in North Texas
dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.
Garwood Medical Device Raises $4M in Series C Funding
Garwood Medical Device, LLC, a Buffalo NY-based company which specializes in developing technology to treat antibiotic-resistant bacterial biofilm infections associated with metallic orthopaedic implants, raised $4M in Series C funding.
The round was led by the WNY Impact Investment Fund and the Murray family, along with global investors in the orthopaedics/health care space.
The company intends to use the funds to expand operations and its business reach.
Led by Wayne Bacon, president & CEO, Garwood Medical Devices is developing technology to eliminate antibiotic-resistant bacterial biofilm infections associated with metallic orthopaedic implants. Its BioPrax™ device is currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures and used alongside the current standard of care. It is currently in pre-clinical trials.